Anti-lymphocyte autoantibodies in systemic lupus erythematosus.

Trans Am Clin Climatol Assoc. 1997; 108: 127–135.

PMCID: PMC2376594

J. B. Winfield, P. D. Fernsten, and J. K. Czyzyk

Thurston Arthritis Research Center, Department of Medicine, University of North Carolina at Chapel Hill 27599, USA.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (983K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Fig. 1
on p.131

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Winfield, JB; Winchester, RJ; Wernet, P; Fu, SM; Kunkel, HG. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum. 1975 18(1):1–8.Jan–Feb; [PubMed]
Winfield, JB; Winchester, RJ; Kunkel, HG. Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum. 1975 18(6):587–594.Nov–Dec; [PubMed]
Avrameas, S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today. 1991 May;12(5):154–159. [PubMed]
Winfield, JB; Shaw, M; Minota, S. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus. J Immunol. 1986 May 1;136(9):3246–3253. [PubMed]
Winfield, JB; Winchester, RJ; Wernet, P; Kunkel, HG. Specific concentration of antilymphocyte antibodies in the serum cryoprecipitates of patients with systemic lupus erythematosus. Clin Exp Immunol. 1975 Mar;19(3):399–406. [PubMed]
Winfield, JB; Cohen, PL; Litvin, DA. Antibodies to activated T cells and their soluble products in systemic lupus erythematosus. Arthritis Rheum. 1982 Jul;25(7):814–819. [PubMed]
Yamada, A; Winfield, JB. Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus. J Clin Invest. 1984 Dec;74(6):1948–1960. [PubMed]
TERASAKI, PI; MCCLELLAND, JD. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. [PubMed]
Yamada, A; Cohen, PL; Winfield, JB. Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus. Preferential reactivity with cells bearing the T4 and autologous erythrocyte receptor phenotypes. Arthritis Rheum. 1985 Mar;28(3):262–270. [PubMed]
Sano, H; Kumagai, S; Namiuchi, S; Uchiyama, T; Yodoi, J; Maeda, M; Takatsuki, K; Suginoshita, T; Imura, H. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines. Clin Exp Immunol. 1986 Jan;63(1):8–16. [PubMed]
Ooi, BS; Ooi, YM; Pesce, AJ; Pollak, VE. Antibodies to beta 2 microglobulin in the sera of patients with systemic lupus erythematosus. Immunology. 1977 Oct;33(4):535–541. [PubMed]
Yamada, A; Shaw, M; Winfield, JB. Surface antigen specificity of cold-reactive IgM antilymphocyte antibodies in systemic lupus erythematosus. Arthritis Rheum. 1985 Jan;28(1):44–51. [PubMed]
Messner, RP; De Horatius, R; Ferrone, S. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives: reactivity with the HLA antigenic molecular complex. Arthritis Rheum. 1980 Mar;23(3):265–272. [PubMed]
Okudaira, K; Searles, RP; Ceuppens, JL; Goodwin, JS; Williams, RC., Jr Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest. 1982 Jan;69(1):17–24. [PubMed]
Pope, RM; Keightley, R; McDuffy, S. Circulating autoantibodies to IgD in rheumatic diseases. J Immunol. 1982 Apr;128(4):1860–1863. [PubMed]
Rekvig, OP. Intrinsic cell membrane antigens recognized by antichromatin autoantibodies. The membrane antigens do not derive from the nucleus. Scand J Immunol. 1989 Jan;29(1):7–13. [PubMed]
Koren, E; Reichlin, MW; Koscec, M; Fugate, RD; Reichlin, M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest. 1992 Apr;89(4):1236–1241. [PubMed]
Noguchi, M; Iwamori, M; Hirano, T; Kobayashi, S; Hashimoto, H; Hirose, S; Nagai, Y. Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia. Ann Rheum Dis. 1992 Jun;51(6):713–716. [PubMed]
Mimura, T; Fernsten, P; Jarjour, W; Winfield, JB. Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus. J Exp Med. 1990 Aug 1;172(2):653–656. [PubMed]
Fernsten, PD; Czyzyk, JK; Mimura, T; Winfield, JB. Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus. Mol Biol Rep. 1994;20(2):85–95. [PubMed]
Czyzyk, J; Fernsten, P; Shaw, M; Winfield, JB. Cell-type specificity of anti-CD45 autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 1996 Apr;39(4):592–599. [PubMed]
Marchalonis, JJ; Schluter, SF; Wang, E; Dehghanpisheh, K; Lake, D; Yocum, DE; Edmundson, AB; Winfield, JB. Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity. Proc Soc Exp Biol Med. 1994 Nov;207(2):129–147. [PubMed]
Trowbridge, IS; Thomas, ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol. 1994;12:85–116. [PubMed]
Rudd, CE; Janssen, O; Cai, YC; da Silva, AJ; Raab, M; Prasad, KV. Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today. 1994 May;15(5):225–234. [PubMed]
Chan, AC; Desai, DM; Weiss, A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol. 1994;12:555–592. [PubMed]
Leitenberg, D; Novak, TJ; Farber, D; Smith, BR; Bottomly, K. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J Exp Med. 1996 Jan 1;183(1):249–259. [PubMed]
Furukawa, T; Itoh, M; Krueger, NX; Streuli, M; Saito, H. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 zeta chain. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10928–10932. [PubMed]
Morimoto, C; Steinberg, AD; Letvin, NL; Hagan, M; Takeuchi, T; Daley, J; Levine, H; Schlossman, SF. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest. 1987 Mar;79(3):762–768. [PubMed]
Itzkowitz, SH; Yuan, M; Montgomery, CK; Kjeldsen, T; Takahashi, HK; Bigbee, WL; Kim, YS. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989 Jan 1;49(1):197–204. [PubMed]
Downward, J; Graves, J; Cantrell, D. The regulation and function of p21ras in T cells. Immunol Today. 1992 Mar;13(3):89–92. [PubMed]
Kawauchi, K; Lazarus, AH; Rapoport, MJ; Harwood, A; Cambier, JC; Delovitch, TL. Tyrosine kinase and CD45 tyrosine phosphatase activity mediate p21ras activation in B cells stimulated through the antigen receptor. J Immunol. 1994 Apr 1;152(7):3306–3316. [PubMed]
Vogel, LB; Fujita, DJ. p70 phosphorylation and binding to p56lck is an early event in interleukin-2-induced onset of cell cycle progression in T-lymphocytes. J Biol Chem. 1995 Feb 10;270(6):2506–2511. [PubMed]